Anti-histone antibodies are particularly associated with which type of condition?

Anti-histone antibodies are particularly associated with which type of condition?

• A. Rheumatoid arthritis
• B. Drug-induced SLE
• C. Vasculitis
• D. Primary biliary cirrhosis

Answer: (B)

Anti-histone antibodies are specifically associated with drug-induced systemic lupus erythematosus (SLE). This condition arises in patients who develop lupus-like symptoms in response to certain medications. The presence of anti-histone antibodies is a distinctive feature of this form of lupus, and their detection often indicates that the patient's symptoms may resolve upon discontinuation of the offending drug. While other autoimmune conditions may involve different types of autoantibodies, drug-induced SLE is unique for its strong association with anti-histone antibodies. These antibodies target histones, which are proteins around which DNA winds, and their presence is particularly indicative of this specific lupus variant as opposed to other autoimmune diseases like rheumatoid arthritis, vasculitis, or primary biliary cirrhosis, which are associated with different serologic markers.

Anti-histone antibodies are specifically associated with drug-induced systemic lupus erythematosus (SLE). This condition arises in patients who develop lupus-like symptoms in response to certain medications. The presence of anti-histone antibodies is a distinctive feature of this form of lupus, and their detection often indicates that the patient's symptoms may resolve upon discontinuation of the offending drug.

While other autoimmune conditions may involve different types of autoantibodies, drug-induced SLE is unique for its strong association with anti-histone antibodies. These antibodies target histones, which are proteins around which DNA winds, and their presence is particularly indicative of this specific lupus variant as opposed to other autoimmune diseases like rheumatoid arthritis, vasculitis, or primary biliary cirrhosis, which are associated with different serologic markers.